It has been reported that IDO can not only affect the infiltration of immune cells in many pathological disease conditions, including liver fibrosis [30, 31], but also further inhibits T cell proliferation and promotes anti-inflammatory macrophage differentiation during MSC therapy [29, 32]. The gene discussed is IDO1; the disease is Hepatic fibrosis.